Document is current
Any future updates will be listed below
-
Authors
Szade, Agata https://orcid.org/0000-0002-0575-4659
Szade, Krzysztof https://orcid.org/0000-0002-7227-4276
Nowak, Witold N https://orcid.org/0000-0002-1526-3511
Bukowska‐Strakova, Karolina https://orcid.org/0000-0001-9181-439X
Muchova, Lucie https://orcid.org/0000-0003-2082-1060
Gońka, Monika
Żukowska, Monika https://orcid.org/0000-0002-2832-2146
Cieśla, Maciej https://orcid.org/0000-0002-8460-1991
Kachamakova‐Trojanowska, Neli https://orcid.org/0000-0002-3226-0726
Rams‐Baron, Marzena
Ratuszna, Alicja
Dulak, Józef https://orcid.org/0000-0001-5687-0839
Józkowicz, Alicja https://orcid.org/0000-0002-7317-260X
-
Funding
Funding for this research was provided by:
European Union (01.02.00‐069/09)
National Science Center (NCN2015/18/M/NZ3/00387)
National Science Center (NCN2013/11/N/NZ3/00956)
Ministry of Science and Higher Education, Republic of Poland (1319/MOB/IV/2015/0)
Ministry of Science and Higher Education, Republic of Poland (1273/MOB/IV/2015/0)
- License Information
-
More Information
Article History
Received: 18 July 2019
Revised: 9 October 2019
Accepted: 15 October 2019
First Online: 11 November 2019
Conflict of interest
: AS, KS, AJ, and JD are the coinventors of the patents US10010557 and US10328085: Cobalt porphyrins for the treatment of blood‐related disorders and EP 3139917: Cobalt protoporphyrin IX for the treatment of blood‐related disorders granted to the Jagiellonian University. The remaining authors declare no conflict of interest.
